Fundraising Fox
Angelini Ventures
Corporate VCRome · Seed–Growth · 7 people tracked
Find your way into Angelini Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Drew Volpe to introduce you to Elia Stupka
You →Drew · together at First Star Ventures →Elia
Ask Jamie Chen to introduce you to Regina Hodits
You →Jamie · together at INiTS | Vienna's High-Tech Incubator →Regina
Ask Sam Okafor to introduce you to Paolo Di Giorgio
You →Sam · together at Pretzel Therapeutics →Paolo
- Tanja Dowe105 people can intro you
Sign up to find every way you can get introduced to Angelini Ventures
- Your email: who you already know at Angelini Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Angelini Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Angelini Ventures builds and invests in companies working to transform healthcare. Backed by a €300 million commitment, the firm invests globally in BioTech and HealthTech businesses. Its focus centers on using technology to improve healthcare delivery, reshape the patient journey, and address unmet needs among vulnerable populations.
Source: firm website, verified Sep 27, 2026.
Team · 7 people
from public directories
What they invest in
from 25 of 36 portfolio companiesHealthtech ×19Biotech ×16Medical Devices ×13Digital Health ×12AI & Machine Learning ×8Deep Tech ×8Mental Health ×3Hardware ×2
HQs:United States×8Switzerland×1Germany×1Italy×1Singapore×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×72 founders×43 founders×14+ founders×2
Where their founders studiedfrom 13 founders with education data
INSEAD ×2
What their founders studiedfrom 14 founders with field-of-study data
Life Sciences ×9Business & Management ×2Engineering ×2
Investments · 36 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 42024 · 22023 · 12022 · 12018 · 112 dated
Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners.
AI & Machine LearningBiotechDeep TechHealthtech
Yves Ribeill(Partner & EIR)inNeill Moray Mackenzie(Partner & EIR)inPoul Sørensen(Partner & EIR)in
BoardRémi Soula(Partner & EIR)
Co-investorsKurma PartnersBpifrance
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Co-investorsTaiwania CapitalDebiopharm Innovation FundFirst Star VenturesScaleX Venturesredalpine
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsKurma PartnersBoehringer Ingelheim Venture FundClavystBioHighlight CapitalSEEDS Capital
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.
BiotechHealthtechMedical Devices
Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in
Co-investorsaMoonRA CapitalBpifranceAndera PartnersKurma PartnersPontifax Venture Capital+1 more
AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US
Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)
Co-investors1/1 Capitalabrdn plcFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsArboretum VenturesAsahi Kasei Corporate Venture CapitalAvestria VenturesShangBay Capital LLC
Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.
BiotechDigital HealthHealthtechMedical DevicesSammamish, US
Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)
Co-investorsJAZZ Venture PartnersLumira VenturesF-Prime CapitalIaso VenturesMayo Clinic Ventures
CoMind develops neuromonitoring devices and neural interfaces aimed at measuring and treating the brain to improve patient outcomes across the care continuum.
Deep TechHardwareHealthtechMedical Devices
James Dacombe(Founder and Chief Executive Officer)inSimon Morling(Chief Technology Officer)inRob Cooper(Chief Scientific Officer)inChema Garcia-Soto(Chief Commercial Officer)inMarc Bloom(Chief Medical Officer)in
Co-investorsBackedCrane Venture PartnersLocalGlobeOctopus VenturesPhoenix Court
Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico.
AI & Machine LearningBiotechDeep Tech
Clarissa Desjardins(Founder)in
Co-investorsOrbiMedAlexandriaDIMENSIONBDC Thrive Venture Fund for WomenLumira VenturesAmplitude Venture Capital+1 more
COUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function.
BiotechHealthtech
Co-investorsAlpha Wave GlobalLumira VenturesRoche Venture FundJDRF T1D Fund
Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.
BiotechDeep TechDigital HealthHealthtechMedical Devices
Co-investorsLumira VenturesNoeticToronto Innovation Acceleration Partners
Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.
BiotechDigital HealthMental Health
Delphine Charvin(Founding Chief Executive Officer & Board Director)inMélanie Rouillier(VP, Chief Operations Officer & Co-Founder)inJocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)in
Co-investorsCARMA FUNDKurma PartnersSambrinvest
Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Lei Stanley Qi(Scientific Founder)inAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)
BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)
Co-investorsAlly Bridge Groupabrdn plcFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.
BiotechFemTechHealthtech
Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)
Co-investorsIndaco Venture PartnersOMX VenturesSofinnova PartnersBill & Melinda Gates Foundation
Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists.
Digital HealthHealthtechMental Health
Sahil Choudhryin
Co-investors25MadisonCobalt VenturesCornucopian Capital ManagementNextView VenturesNVP CapitalRPS Ventures+4 more
.png)
HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture.
AI & Machine LearningDeep TechDefense TechHardwareAlexandria, US
Matthew Theurer(Executive Officer, Director)Lauren Stack(Executive Officer, Director)inVincent Lubsey(Executive Officer)
BoardJuan Lopez(Director)inWilliam Porteous(Director)in
Co-investorsKibo VenturesGlade Brook Capital PartnersHeal CapitalLifeX VenturesRRE VenturesZEISS Ventures
Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.
AI & Machine LearningHealthtechMedical Devices
Co-investorsHeal CapitalHeran PartnersLifeX VenturesMeridian Health VenturesSonorcapZEISS Ventures+1 more
Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.
BiotechHealthtech
Co-investorsCurie CapitalKurma Partners
Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.
AI & Machine LearningHealthtechIoT
Roeland Pelgrims(Founder)in
Co-investors15th RockEQT Life SciencesPMV
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in
Co-investorsBlue Venture FundsJoyance PartnersOrbiMedTreo Ventures, LlcZühlke VenturesBridge Bank+2 more
Immunotherapy company developing NOUS-209 for the prevention of Lynch syndrome-associated cancers.
Co-investors5AM VenturesAndera PartnersCDP Venture CapitalIndaco Venture PartnersM VenturesRevelation Partners+5 more
Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.
BiotechDeep TechHealthtechMedical DevicesBasel, CH
Leila Jaafar(CEO)Gustav(Medical Advisor)
Co-investorsDeepTech & Climate FondsKurma PartnersNeva Sgr.VIVES Partners
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)inGabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)
Co-investorsARCH Venture PartnersCambridge Innovation CapitalEIR VenturesGV (Google Ventures)HealthCapInvus+1 more
Serenis is an online mental health platform offering video sessions with vetted psychologists, psychotherapists, psychiatrists, coaches, and nutritionists, covering individual, couples, ADHD, psychiatry, sexology, and eating-disorder care.
Digital HealthMarketplacesMental Health
Daniele Francescon(Founder)in
Co-investorsGruppo BertoldiLumen VenturesCDP Venture CapitalInvictus Capital
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsDementia Discovery FundDolby Family VenturesMitsui Global Investment+2 more
Vantis develops AI-based assistance systems and technology for primary care, aimed at supporting physicians in everyday clinical work by simplifying processes and making medical information more usable.
AI & Machine LearningDigital HealthHealthtechMunich, DE
Maximilian Roedel(Founder)
Co-investorsBayBG Venture CapitalBayern Kapitalb2venturefirstminute capital
.jpeg){kind=logo}
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Arclight TherapeuticsArgobioCongruenceCourExtendGenEpHandspringHypervision SurgycalNEUmiRNANoctrix
Portfolio news
latest coverage across their companiesEpicrispr Biotechnologies · finsmes.com · Aug 11, 2026
Serenis · finsmes.com · Oct 3, 2025
Noctrix Health · finsmes.com · Sep 2, 2025
Pretzel Therapeutics · finsmes.com · Jul 14, 2025
Elkedonia · finsmes.com · Jun 11, 2025
Frequently asked questions
- How many investments has Angelini Ventures made?
- Angelini Ventures has 36 tracked investments, including 7 dated in the last 24 months.
- What stage does Angelini Ventures invest at?
- Angelini Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Angelini Ventures focus on?
- Angelini Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health.
- Where is Angelini Ventures located?
- Angelini Ventures is headquartered in Rome, IT.
- Does Angelini Ventures lead rounds?
- Angelini Ventures has led 6 of the 12 rounds where its role is on record.
- Who does Angelini Ventures co-invest with?
- Angelini Ventures most often shares deals with Kurma Partners, Lumira Ventures, Dolby Family Ventures, among 64 tracked co-investors.
- What size deals does Angelini Ventures back?
- Across 5 deals with disclosed amounts, Angelini Ventures has joined rounds of $22M – $40M (median $37M).
Media · Podcasts & interviews
featuring the teamElia Stupka, Angelini Ventures
The Health Care Blog's Channel · Elia Stupka
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Equitage Ventures is an early-stage venture firm that provides capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults.
P5 Health Ventures (P5HV) is an investment firm with a primary focus on healthcare technologies, backing companies that use AI and technology to lower the cost of care while improving quality and accessibility.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.